Global Nuclear Imaging Devices Market Size By Type (SPECT, PET), By Application (Oncology, Cardiology), By Region, And Segment Forecasts, 2023 to 2032

The Global Nuclear Imaging Devices Market was valued at USD 3.1 billion in 2023 and is projected to reach USD 5.4 billion by 2031, growing at a CAGR of 7.3% during the forecast period from 2023 to 2031. Nuclear imaging devices, which include PET and SPECT systems, are pivotal in the early diagnosis and effective management of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders. The market is experiencing robust growth due to rising demand for early-stage disease detection, increasing prevalence of chronic conditions, advancements in hybrid imaging technologies, and expanding geriatric populations worldwide.

Drivers:

1. Growing Burden of Chronic Diseases:

An increasing global incidence of cancer, neurological disorders, and cardiovascular diseases is driving the need for advanced diagnostic imaging systems. Nuclear imaging facilitates early diagnosis and real-time disease monitoring.

2. Technological Advancements in Imaging Devices:

Integration of AI with nuclear imaging, development of hybrid imaging systems (PET/CT and SPECT/CT), and improved radiotracer development are enhancing diagnostic precision and fueling adoption rates.

3. Rising Geriatric Population:

The aging global population is more susceptible to chronic diseases, which in turn is increasing the demand for efficient and non-invasive diagnostic tools such as nuclear imaging devices.

Restraints:

1. High Cost of Equipment and Procedures:

Nuclear imaging systems involve substantial upfront investment and ongoing operational costs, including radiopharmaceutical handling, making them less accessible in low-income healthcare settings.

2. Regulatory and Reimbursement Challenges:

Stringent regulatory frameworks and inadequate reimbursement policies in some countries pose significant hurdles to the widespread adoption of nuclear imaging technologies.

Opportunity:

1. Emerging Markets and Healthcare Infrastructure Development:

Rapid healthcare advancements and increasing diagnostic investments in emerging markets like India, Brazil, and Southeast Asia are opening new avenues for growth.

2. Expansion of Personalized Medicine:

Rising interest in precision diagnostics and personalized treatment regimens is increasing the demand for nuclear imaging, especially in oncology and neurology.

3. Innovation in Radiopharmaceuticals:

The development of novel radioisotopes and targeted tracers is enhancing the functional imaging capabilities of nuclear devices, thus expanding their applications across diverse medical specialties.

Market by System Type Insights:

In 2023, the SPECT Systems segment held the largest share of the nuclear imaging devices market. SPECT systems are widely adopted due to their affordability and broad clinical utility, especially in cardiology. However, the PET Systems segment is anticipated to witness the fastest growth, driven by superior image resolution, rising oncological applications, and improved tracer availability.

Market by End-use Insights:

Hospitals dominated the market in 2023, accounting for over 50% of total revenue. Their integration with radiopharmaceutical supply chains and presence of advanced diagnostic infrastructure makes them primary adopters. The diagnostic imaging centers segment is expected to grow rapidly, benefiting from the decentralization of healthcare services and increasing demand for outpatient diagnostic solutions.

Market by Regional Insights:

North America led the market in 2023, driven by well-established healthcare infrastructure, early technology adoption, and favorable reimbursement structures. Asia-Pacific is expected to witness the highest growth through 2031, with rising healthcare investments, a large aging population, and expanding awareness of nuclear medicine in countries like China, India, and Japan.

Competitive Scenario:

Key players in the global nuclear imaging devices market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Digirad Corporation, Positron Corporation, and Curium Pharma. These companies are focusing on R&D, regulatory approvals, and strategic partnerships to expand their global footprint and enhance device performance.

Key Developments:

In 2023, GE Healthcare launched a new digital PET scanner featuring AI-based image reconstruction for faster and more precise diagnostics.

In 2024, Siemens Healthineers acquired a radiopharmaceutical firm to secure a steady supply chain of high-quality tracers for their PET systems.

In 2025, Philips announced the integration of cloud-based analytics into their SPECT systems, enhancing remote diagnostics capabilities.

Scope of Work – Global Nuclear Imaging Devices Market

Report Metric Details

Market Size (2023) USD 3.1 billion

Projected Market Size (2031) USD 5.4 billion

CAGR (2023-2031) 7.3%

Market Segments By System Type (SPECT, PET), By End-Use (Hospitals, Diagnostic Centers), By Region

Growth Drivers Rising chronic disease prevalence, aging population, advancements in imaging technology

Opportunities Growth in emerging markets, personalized medicine, innovation in radiopharmaceuticals

FAQs:

1) What is the current market size of the Global Nuclear Imaging Devices Market?

The market was valued at USD 3.1 billion in 2023.

2) What is the major growth driver of the Global Nuclear Imaging Devices Market?

The major growth driver is the increasing prevalence of chronic diseases such as cancer and cardiovascular conditions, demanding early and accurate diagnostics.

3) Which is the largest region during the forecast period in the Global Nuclear Imaging Devices Market?

North America holds the largest share due to its advanced healthcare systems and early adoption of technology.

4) Which segment accounted for the largest market share in the Global Nuclear Imaging Devices Market?

The SPECT Systems segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Nuclear Imaging Devices Market?

Key players include GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Digirad Corporation, and Curium Pharma.